Sign in
Taking peopleNo phase

Anti-fog suction device during nose-route surgery for pituitary adenoma or craniopharyngioma

Tests a lens anti-fog suction device in adults having pituitary region tumor surgery.

Key facts

Who runs it
West China Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
Status
Recruiting
People taking part
20 people, planned
Started
1 Mar 2026
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Anti-fog suction device-a 4 Fr multi-channel silicone catheter
Record updated
30 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a pituitary adenoma or craniopharyngioma who are planned for surgery through the nose with an endoscope. It tests a device that keeps the camera lens from fogging.

Age
18 to 75 years
Sex
All sexes
Disease stage
Pituitary adenoma or craniopharyngioma of ≤ 3 cm (1.2 in) on MRI/CT, without extensive spread into the skull base. Planned elective endoscopic endonasal transsphenoidal surgery. General health ASA class I-III.
Earlier treatment
People whose earlier nose surgery prevents placing the device cannot join.

Main reasons for not taking part

  • Severe nose deformity, polyps or earlier nose surgery that prevents placing the device
  • Active nose or body-wide infection (WBC > 10 × 10⁹/L, CRP ≥ 10 mg/L), known brain infection or ongoing CSF (brain fluid) leak
  • Blood clotting problems (PT > 14 s or APTT > 45 s) or blood thinners that cannot be stopped for ≥ 7 days
  • Allergy to silicone or medical-grade plastics, or a planned combined approach through the skull or eye socket
  • Pregnancy or breastfeeding, or a mental or cognitive disorder that prevents consent or follow-up

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age 18-75 years
  • Pre-operative MRI/CT diagnosis of pituitary adenoma or craniopharyngioma ≤ *3 cm without extensive skull-base invasion
  • Scheduled for elective endoscopic endonasal transsphenoidal resection
  • ASA physical status I-III
  • Able and willing to give written informed consent and comply with follow-up

Who cannot take part

  • Severe nasal anatomical deformity, polyps, or prior nasal surgery preventing device placement
  • Known intracranial infection or ongoing CSF leak
  • Allergy to silicone or medical-grade plastics
  • Psychiatric or cognitive disorder precluding informed consent or follow-up
  • Active nasal or systemic infection (WBC > 10 × 10⁹/L, CRP ≥ 10 mg/L)
  • Coagulopathy (PT > 14 s or APTT > 45 s) or anticoagulation that cannot be stopped ≥ 7 days
  • Planned combined transcranial or transorbital approach
  • Pregnancy or breastfeeding

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if the anti-fog suction device works to keep the surgical view clear during endoscopic nose-to-pituitary operations and whether it lowers the chance of brain-fluid infection. It will also learn about the safety of the device.

Read full original descriptionShow less

The main questions it aims to answer are:

* Does the device reduce the total time the surgeon has to stop because the lens fogs up? * What medical problems (such as nose-bleed, tube blockage, or infection) do participants have when the device is used?

Researchers will compare the anti-fog device to the usual "water-squirt" method to see if the device works better.

Participants will:

* Have either the device or the usual water method applied during their planned pituitary surgery * Stay in the hospital for the normal recovery period (about 3-5 days) and return for a routine check-up around day 7 * Allow the study team to record operating times, any fog-related pauses, and results of blood or spinal-fluid tests taken before and after surgery

The 2 groups in the trial

  • Intervention groupTreatment being tested

    A single-use, sterile "anti-fog suction device" (a 4 Fr multi-channel silicone catheter) is introduced through the same nostril alongside the endoscope after induction of anaesthesia. The built-in micro-balloon is inflated with 1 ml air to anchor the tip in the posterior choana. Low-flow (2 L min-¹), filtered, room-temperature air is delivered through the central lumen, creating a gentle laminar stream that passes across the lens, continuously removing warm humid air and preventing condensation. Two side ports provide continuous low-pressure (-5 cmH₂O) suction of any blood or fluid, keeping the surgical field dry. The device remains in place for the entire operation and is removed before nasal packing. No extra incisions or sutures are required.

    Treatment: Anti-fog suction device-a 4 Fr multi-channel silicone catheter

  • Control groupNo study treatment, for comparison

    Standard care: whenever the lens fogs, the scrub nurse withdraws the endoscope and irrigates its tip with 5-10 ml of 37 °C sterile saline from a 20 ml syringe. This manoeuvre is repeated as often as necessary (average 10-15 times per case).

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
Plain-language title
Anti-fog suction device during nose-route surgery for pituitary adenoma or craniopharyngiomaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT07316101, who can take part
Record updated
30 June 2026
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery (NCT07316101) – Frontlight Research